Essential thrombocythemia. Therapy with interferon alfa.

• Autor(es): Lebre, L ; Sousa, A ; Sampaio, J ; Novais, L ; Júnior, E ; Coelho, R ; Simões, J
• Data: 1991
• Origem: Acta Médica Portuguesa
• Tipo de Documento: Artigo científico
• Idioma: Português

Descrição

A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.

A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.